See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Accuray Incorporated (ARAY) - free report >>
Wayfair Inc. (W) - free report >>
Innoviva, Inc. (INVA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Accuray Incorporated (ARAY) - free report >>
Wayfair Inc. (W) - free report >>
Innoviva, Inc. (INVA) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 1st
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Accuray Incorporated (ARAY - Free Report) : This designer and developer of radiosurgery and radiation therapy systems for the treatment of tumors has seen the Zacks Consensus Estimate for its current year earnings increasing moiré than 100% over the last 60 days.
Accuray Incorporated Price and Consensus
Accuray Incorporated price-consensus-chart | Accuray Incorporated Quote
Emerald Holding, Inc. (EEX - Free Report) : This operator of business-to-business (B2B) trade showshas seen the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
Emerald Expositions Events, Inc. Price and Consensus
Emerald Expositions Events, Inc. price-consensus-chart | Emerald Expositions Events, Inc. Quote
Kiniksa Pharmaceuticals, Ltd. (KNSA - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.
Kiniksa Pharmaceuticals, Ltd. Price and Consensus
Kiniksa Pharmaceuticals, Ltd. price-consensus-chart | Kiniksa Pharmaceuticals, Ltd. Quote
Wayfair Inc. (W - Free Report) : This company that engages in e-commerce business has seen the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Wayfair Inc. Price and Consensus
Wayfair Inc. price-consensus-chart | Wayfair Inc. Quote
Innoviva, Inc. (INVA - Free Report) : This developer and commercializer of pharmaceuticals has seen the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
Innoviva, Inc. Price and Consensus
Innoviva, Inc. price-consensus-chart | Innoviva, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>